STEVENS CAPITAL MANAGEMENT LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 280 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2020$255,000
-41.8%
14,030
-36.8%
0.12%
+204.9%
Q4 2019$438,000
+78.8%
22,190
+55.6%
0.04%
+86.4%
Q3 2019$245,000
-68.7%
14,262
-62.9%
0.02%
-33.3%
Q1 2019$783,00038,4390.03%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2024
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,444,010$22,685,3975.23%
Capricorn Fund Managers Ltd 868,417$13,642,8314.90%
TFG Asset Management GP Ltd 1,903,662$29,906,5304.04%
MANAGED ASSET PORTFOLIOS, LLC 1,711,125$26,881,7824.04%
Clean Yield Group 544,042$8,546,9003.52%
Mondrian Investment Partners LTD 4,081,715$64,123,7431.28%
Sippican Capital Advisors 80,799$1,269,3521.17%
XY Capital Ltd 78,031$1,225,8670.88%
Legacy Wealth Asset Management, LLC 124,116$1,949,8620.68%
BRANDES INVESTMENT PARTNERS, LP 1,765,319$27,733,1590.56%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders